Jafar Sadik B. Shaik, PhD (he/him/his)

Associate Director
Johnson & Johnson Innovative Medicine

Poster(s):

• (T-083) Exposure-Response Analysis of Guselkumab in Induction Studies in Adults with Moderately to Severely Active Ulcerative Colitis in the QUASAR Program
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT